Furthermore, targeting eIF5A2 attenuats tumor growth and metastasis as well as overcomes chemotherapeutic resistance [12–15], suggesting that targeting eIF5A2 may provide an effective approach for the treatment of malignancies. This evidence concerns the gene EIF5A2 and neoplasm.